Trial Profile
Impact of Periodontal Therapy on Metabolic and Inflammatory Markers in Chronic Kidney Disease Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Minocycline (Primary)
- Indications Bacterial infections; Dental infections; Periodontitis
- Focus Pharmacodynamics
- Acronyms KPU
- 04 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Feb 2010 Planned end date changed from 1 Dec 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.